glp-1 ckd and the kidney: from physiology to pharmacology and outcomes in diabetes Preventing diabetic kidney disease progression:
Description
It is also important to consider the unique individual responses to weight loss and its indirect effects among those taking GLP-1 agonists [61]
10.1002/cne.902710405 [DOI] [PubMed] [Google Scholar] Kahles, F
Long-Term Progress and Weight Maintenance Considerations GLP-1 medications are generally most effective when viewed as part of a longer-term weight management strategy rather than a short-term intervention
Incretin action in islets and implications for diabetes The findings that the acute insulinotropic actions of GLP-1, but not GIP, were relatively preserved in people with type 2 diabetes (T2D) (2) focused greater attention on the therapeutic potential of GLP-1, ultimately supporting multiple clinical development programs for GLP-1 receptor (GLP-1R) agonists (GLP-1RA)
Jana BA, Wadhwani AD
doi: 10.1093/jnci/djae260 [DOI] [PMC free article] [PubMed] [Google Scholar] 11.Wang L, Xu R, Kaelber DC, Berger NA
